Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/31842| Title: | Acute Vasoreactivity Testing and Outcomes in Pulmonary Arterial Hypertension: A Call for Increased Testing. | Austin Authors: | Chandrasekara, S;Lau, E M;Anderson, J;Collins, N;Cordina, R;Corrigan, C;Dwyer, N;Feenstra, J;Horrigan, Mark ;Keogh, A;Kotlyar, E;Lavender, M;McWilliams, T;Rhodes, B;Steele, P;Strange, G;Thakkar, V;Weintraub, R;Whitford, H;Whyte, K;Williams, T ;Wrobel, J;Keating, D T | Affiliation: | School of Medicine, University of Notre Dame, Fremantle, WA, Australia. Department of Respiratory Medicine, The Alfred Hospital, and Central Clinical School, Monash University, Melbourne, Vic, Australia. School of Medicine, University of Notre Dame, Fremantle, WA, Australia Pulmonary Hypertension Society of Australia and New Zealand. Department of Clinical Medicine, Macquarie University, Sydney, NSW, Australia Department of Rheumatology, Liverpool Hospital, Sydney, NSW, Australia. Royal Children's Hospital, Melbourne, Vic, Australia Murdoch Children's Research Institute, Melbourne, Vic, Australia University of Melbourne, Melbourne, Vic, Australia. Advanced Lung Disease Unit, Fiona Stanley Hospital, Perth, WA, Australia Sydney Medical School, University of Sydney, Sydney, NSW, Australia. Respiratory Department, Sunshine Coast University Hospital, Birtinya, Qld, Australia. Department of Cardiology, John Hunter Hospital, Newcastle, NSW, Australia. Department of Cardiology, Royal Prince Alfred Hospital, and Heart Research Institute, Sydney, NSW, Australia. Heart and Lung Transplant Unit, St Vincent's Hospital, Sydney, NSW, Australia. Department of Cardiology, Royal Hobart Hospital, Hobart, Tas, Australia. Queensland Lung Transplant Service, Prince Charles Hospital, Brisbane, Qld, Australia. Austin Health Heart and Lung Transplant Unit, St Vincent's Hospital, Sydney, NSW, Australia. Heart and Lung Transplant Unit, St Vincent's Hospital, Sydney, NSW, Australia. Advanced Lung Disease Unit, Fiona Stanley Hospital, Perth, WA, Australia. Greenlane Clinical Centre, Auckland City Hospital, Auckland, New Zealand. Department of Respiratory Medicine, Christchurch Hospital, Christchurch, New Zealand. Department of Cardiovascular Services, Royal Adelaide Hospital, Adelaide, SA, Australia. Department of Respiratory Medicine, The Alfred Hospital, and Central Clinical School, Monash University, Melbourne, Vic, Australia. Greenlane Clinical Centre, Auckland City Hospital, Auckland, New Zealand. Department of Respiratory Medicine, The Alfred Hospital, and Central Clinical School, Monash University, Melbourne, Vic, Australia. |
Issue Date: | 8-Feb-2023 | Date: | 2022 | Publication information: | Heart, Lung and Circulation (2023) 32, 156–165 | Abstract: | Pulmonary arterial hypertension (PAH) has a progressive, unremitting clinical course. Vasoreactivity testing (VdT) during right heart catheterisation (RHC) identifies a subgroup with excellent long-term response to calcium channel blockade (CCB). Reporting on these patients is limited. Established in 2011, the Pulmonary Hypertension Society of Australia and New Zealand (PHSANZ) registry offers the opportunity to assess the frequency of VdT during RHC, treatment and follow up of PAH patients. | URI: | https://ahro.austin.org.au/austinjspui/handle/1/31842 | DOI: | 10.1016/j.hlc.2022.09.005 | ORCID: | Journal: | Heart, Lung & Circulation | PubMed URL: | 36503731 | ISSN: | 1444-2892 | Type: | Journal Article | Subjects: | Calcium channel blockers Pulmonary hypertension Right heart catheter Right ventricular failure Vasoreactivity testing |
| Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.